TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Pharmaceutical Preparations · Healthcare · $30.9B
Intrinsic Value (Consensus)
$17.38
Current Price
$32.91
Margin of Safety
-47.2%
47.2% Above Intrinsic Value
Value: $17
Price: $33
Valuation Model Estimates
Current Price: $32.91
DCF (Discounted Cash Flow)
$18.43
Graham Number
$15.14
Earnings Power Value
$11.75
Relative Value (P/E)
$24.20
Dividend Discount Model
Not applicable
—
Consensus Value
$17.38
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
D
48
Profitability
22/25
Strength
12/25
Valuation
7/25
Growth
7/25
Financial Health Signals
Very high debt — Debt/Equity ratio is 364% (above 200% is risky)
Key Financials
- EPS (TTM)
- $1.21
- EPS (Forward)
- $1.27
- Book Value
- $8.41
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 17.8%
- Debt/Equity
- 364%
- Revenue Growth
- 4.3%
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance